Evidence map›Paper›PMID 36479628›Full record

ArticleMicrobiologyOpen2022

The emergence of the tetrathionate reductase operon in the Escherichia coli/Shigella pan-genome.

Floyd G Adsit, Thomas A Randall, Jacqueline Locklear, David M Kurtz

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Floyd G AdsitQuality Assurance Laboratory (QAL), Comparative Medicine Branch (CMB), National Institute of Environmental Health Sciences (NIEHS), Durham, North Carolina, USA.ORCID 0000-0002-1971-3604
Thomas A RandallIntegrative Bioinformatics, National Institute of Environmental Health Sciences (NIEHS), Durham, North Carolina, USA.ORCID 0000-0002-4605-7606
Jacqueline LocklearQuality Assurance Laboratory (QAL), Comparative Medicine Branch (CMB), National Institute of Environmental Health Sciences (NIEHS), Durham, North Carolina, USA.
David M KurtzQuality Assurance Laboratory (QAL), Comparative Medicine Branch (CMB), National Institute of Environmental Health Sciences (NIEHS), Durham, North Carolina, USA.
National Institute of Environmental Health Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli pathogenic variants (pathovars) are generally characterized by defined virulence traits and are susceptible to the evolution of hybridized identities due to the considerable plasticity of the E. coli genome. We have isolated a strain from a purified diet intended for research animals that further demonstrates the ability of E. coli to acquire novel genetic elements leading potentially to emergent new pathovars. Utilizing next generation sequencing to obtain a whole genome profile, we report an atypical strain of E. coli, EcoFA807-17, possessing a tetrathionate reductase (ttr) operon, which enables the utilization of tetrathionate as an electron acceptor, thus facilitating respiration in anaerobic environments such as the mammalian gut. The ttr operon is a potent virulence factor for several enteric pathogens, most prominently Salmonella enterica. However, the presence of chromosomally integrated tetrathionate reductase genes does not appear to have been previously reported in wild-type E. coli or Shigella. Accordingly, it is possible that the appearance of this virulence factor may signal the evolution of new mechanisms of pathogenicity in E. coli and Shigella and may potentially alter the effectiveness of existing assays using tetrathionate reductase as a unique marker for the detection of Salmonella enterica.

Indexed as

Escherichia coliShigellaOxidoreductasesVirulence FactorsOxidoreductasestetrathionate reductaseVirulence FactorsEscherichia colipathogenShigellatetrathionate respirationvirulence factor

Identifiers

PMID36479628
PMCPMC9638481
OpenAlexW4308448082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.